Abstract
Tetracyclines are a class of antibiotics that function by inhibiting protein synthesis. Although they have a very broad spectrum of antibacterial activity, their current clinical use is primarily for the treatment of intracellular organisms like Mycoplasma, Chlamydia, and Rickettsia. They are also used as alternative agents for the treatment of syphilis in the case of penicillin allergy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Chambers, H. F. (2019). Omadacycline- the newest tetracycline. N Engl J Med, 380:588–589.
Chemaly, R. F., Hanmod, S. S., Jiang, Y., Rathod, D. B., Mulanovich, V., Adachi, J. A., et al. (2009). Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution. Medicine (Baltimore), 88(4), 211–220.
Edson, R. S., Bundrick, J. B., & Litin, S. C. (2011). Clinical pearls in infectious diseases. Mayo Clin Proc, 86(3), 245–248.
Moore, A. Y, Charles, J. E. M., Moore, S. (2019). Sarecycline: a narrow-spectrum tetracycline for the treatment of moderate to severe acne vulgaris. Future Microbiol, 14:1235–1242.
O’Riordan, W., Green, S., Overcash, S., Puljiz, I., Metallidis, S., Gardovskis, J., Garrity-Ryan, L., Das, A., Tzanis, E., Eckburg, P. B., Manley, A., Villano, S. (2019). Omadacycline for acute bacterial skin and skin structure infections. N Engl J Med, 380:528–538.
Roberts, J. A., & Lipman, J. (2009). Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med, 37(3), 840–851; quiz 859.
Seysara (R) (sarecycline) [prescribing information]. Madison, NJ: Allergan USA, Inc; October 2018.
Smilack, J. D. (1999). The tetracyclines. Mayo Clin Proc, 74(7), 727–729. Tigecycline (tygacil). (2005). Med Lett Drugs Ther, 47(1217), 73–74.
Stets, R., Popescu, M., Gonong, J. R., Mitha, I., Nseir, W., Madez, A., Kirsch, C., Das, A. F., Garrity-Ryan, L., Steenbergen, J. N., Manley, A., Eckburg, P. B. (2019). Omadacycline for community-acquired bacterial pneumoniae. N Engl J Med, 380:517–527.
Xerava (eravacycline) [prescribing information]. Watertown, MA: Tetraphase Pharmaceuticals Inc; August 2018.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Finberg, R.W., Guharoy, R. (2021). Tetracyclines. In: Clinical Use of Anti-infective Agents. Springer, Cham. https://doi.org/10.1007/978-3-030-67459-5_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-67459-5_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-67458-8
Online ISBN: 978-3-030-67459-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)